首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Molecular docking studies of anti-apoptotic BCL-2, BCL-XL, and MCL-1 proteins with ginsenosides from Panax ginseng
【24h】

Molecular docking studies of anti-apoptotic BCL-2, BCL-XL, and MCL-1 proteins with ginsenosides from Panax ginseng

机译:抗凋亡的BCL-2,BCL-XL和MCL-1蛋白与人参中人参皂苷的分子对接研究

获取原文
           

摘要

Anti-apoptotic proteins such as BCL-2, BCL-XL and MCL-1 bind with pro-apoptotic proteins to induce apoptosis mechanism. BCL-2 family proteins are key regulators of apoptosis process. Over expression of these anti-apoptotic proteins lead to several cancers by preventing apoptosis. A number of studies revealed that ginseng derivatives reduce tumor growth. Ginseng, the most valuable medicinal herb found in eastern Asia belongs to Araliaceae family. In this study, docking simulations were performed for anti-apoptotic proteins with several ginsenosides from Panax ginseng. Our finding shows ginsenosides Rf, Rg1, Rg3 and Rh2 have more binding affinity with BCL-2, BCL-XL and MCL-1 and other ginsenosides also interact with each anti-apoptotic proteins. Therefore, ginseng derivatives represent a novel class of potent inhibitors and could be used for cancer chemotherapy.
机译:抗凋亡蛋白如BCL-2,BCL-XL和MCL-1与促凋亡蛋白结合以诱导凋亡机制。 BCL-2家族蛋白是细胞凋亡过程的关键调节因子。这些抗凋亡蛋白的过度表达通过阻止细胞凋亡而导致多种癌症。大量研究表明,人参衍生物可降低肿瘤的生长。人参是东亚地区发现的最有价值的草药,隶属于金莲花科。在这项研究中,对抗凋亡蛋白与人参中的几种人参皂苷进行了对接模拟。我们的发现表明人参皂苷Rf,Rg1,Rg3和Rh2与BCL-2,BCL-XL和MCL-1具有更高的结合亲和力,其他人参皂苷也与每种抗凋亡蛋白发生相互作用。因此,人参衍生物代表了一类新型的强效抑制剂,可用于癌症化学疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号